RFP | February 4, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Medications Development Centers of Excellence Cooperative Program (MDCE) (U54) Grant. The purpose of this grant is to support MDCEs focused on research directed towards the development of pharmacotherapies for the treatment of substance use disorders. The top priority is in the areas of unmet clinical needs (stimulant- and cannabis-use disorders). Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact for this program . . .